Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Plasma cell 2Myeloid 2Lymphoid 2Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 24Leukemia 22Myelodysplastic Syndromes 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma 16Leukemia, Lymphocytic, Chronic, B-Cell 15Hodgkin Disease 15Lymphoma, Non-Hodgkin 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Multiple Myeloma 12Hematologic Neoplasms 9Primary Myelofibrosis 8Myeloproliferative Disorders 8Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Graft vs Host Disease 6Congenital Abnormalities 6Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelomonocytic, Juvenile 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Accelerated Phase 5Waldenstrom Macroglobulinemia 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Immunoblastic 4Burkitt Lymphoma 4Blast Crisis 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, T-Cell 3

Interventions

Cytarabine 9fludarabine 5Imatinib Mesylate 5thymoglobulin 3fludarabine phosphate 3Tacrolimus 3Sirolimus 3Methotrexate 3Cyclophosphamide 3Busulfan 3Azacitidine 3zosuquidar trihydrochloride 2venetoclax 2ponatinib 2nilotinib 2enasidenib 2bosutinib 2RO6839921 2Mycophenolic Acid 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Behavior Therapy 2Antilymphocyte Serum 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2spartalizumab 1sabatolimab 1quizartinib 1plerixafor 1pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid × thymoglobulin × Clear all
NCT02916979 2023-10-18

FluBuATG

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
20 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Primary Myelofibrosis

NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

NCT00133367 2016-07-25

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

Massachusetts General Hospital

Phase 2 Completed
32 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡